Prophylactic and therapeutic efficacy of a fully human immunoglobulin G1 monoclonal antibody to Pseudomonas aeruginosa alginate in murine keratitis infection

Infection and Immunity

Volumn 76, Issue 10, 2008, Pages 4720-4725

  Zaidi, Tanweer ^a   Pier, Gerald B ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; IMMUNOGLOBULIN G1 ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY F429; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM ISOLATE; COMPARATIVE STUDY; CONTROLLED STUDY; CORNEA INJURY; IMMUNITY; KERATITIS; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROPHYLAXIS; PSEUDOMONAS AERUGINOSA;

ALGINATES; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; COLONY COUNT, MICROBIAL; COMPLEMENT SYSTEM PROTEINS; CORNEA; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; KERATITIS; MICE; MICROBIAL VIABILITY; OPSONIN PROTEINS; PHAGOCYTOSIS; PSEUDOMONAS AERUGINOSA;

EID: 53649088151     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00496-08     Document Type: Article

References (29)

1. Allewelt, M., F. T. Coleman, M. Grout, G. P. Priebe, and G. B. Pier. 2000. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infect. Immun. 68:3998-4004.
2. Bragonzi, A., D. Worlitzsch, G. B. Pier, P. Timpert, M. Ulrich, M. Hentzer, J. B. Andersen, M. Givskov, M. Conese, and G. Doring. 2005. Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. J. Infect. Dis. 192:410-419.
3. Brown, D. M., and C. D. Regillo. 2007. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am. J. Ophthalmol. 144:627-637.
4. Chusid, M. J., D. B. Nelson, and L. A. Meyer. 1986. The role of the polymorphonuclear leukocyte in the induction of corneal edema. Investig. Ophthalmol. Vis. Sci. 27:1466-1469.
5. Cole, N., E. Hume, S. Khan, M. Madigan, A. J. Husband, L. Garthwaite, and M. Willcox. 2005. Contribution of the cornea to cytokine levels in the whole eye induced during the early phase of Pseudomonas aeruginosa challenge. Immunol. Cell Biol. 83:301-306.
6. Diehn, J. J., M. Diehn, M. F. Marmor, and P. O. Brown. 2005. Differential gene expression in anatomical compartments of the human eye. Genome Biol. 6:R74.
7. Fleiszig, S. M. J., T. S. Zaidi, R. Ramphal, and G. B. Pier. 1994. Modulation of Pseudomonas aeruginosa adherence to the corneal surface by mucus. Infect. Immun. 62:1799-1804.
8. Garner, C. V., D. DesJardins, and G. B. Pier. 1990. Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide. Infect. Immun. 58:1835-1842.
9. Hsiao, C. H., L. Yeung, D. H. Ma, Y. F. Chen, H. C. Lin, H. Y. Tan, S. C. Huang, and K. K. Lin. 2007. Pediatric microbial keratitis in Taiwanese children: a review of hospital cases. Arch. Ophthalmol. 125:603-609.
10. Kohler, T., C. van Delden, L. K. Curty, M. M. Hamzehpour, and J. C. Pechere. 2001. Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa. J. Bacteriol. 183:5213-5222.
11. Kosakai, M., and Z. Yosizawa. 1979. A partial modification of the carbazole method of Bitter and Muir for quantitation of hexuronic acids. Anal. Biochem. 93:295-298.
12. Mah-Sadorra, J. H., S. G. Yavuz, D. M. Najjar, P. R. Laibson, C. J. Rapuano, and E. J. Cohen. 2005. Trends in contact lens-related corneal ulcers. Cornea 24:51-58.
13. Mela, E. K., I. P. Giannelou, K. X. John, and G. P. Sotirios. 2003. Ulcerative keratitis in contact lens wearers. Eye Contact Lens 29:207-209.
14. Ohl, C. A., and M. Pollack. 2005. Infections due to Pseudomonas species and related organisms, p. 889-897. In D. L. Kasper, E. Braunwald, A. S. Fauci, S. L. Hauser, D. L. Longo, and J. L. Jameson (ed.), Harrison's principles of internal medicine, 16th ed. McGraw-Hill Book Co., New York, NY.
15. Pachigolla, G., P. Blomquist, and H. D. Cavanagh. 2007. Microbial keratitis pathogens and antibiotic susceptibilities: a 5-year review of cases at an urban county hospital in north Texas. Eye Contact Lens 33:45-49.
16. Pennington, J. E., W. F. Hickey, L. L. Blackwood, and M. A. Arnaut. 1981. Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs. J. Clin. Investig. 68:1140-1148.
17. Pier, G. B. 2007. Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity. Int. J. Med. Microbiol. 297:277-295.
18. Pier, G. B., D. Boyer, M. Preston, F. T. Coleman, N. Llosa, S. Mueschenborn-Koglin, C. Theilacker, H. Goldenberg, J. Uchin, G. P. Priebe, M. Grout, M. Posner, and L. Cavacini. 2004. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. J. Immunol. 173:5671-5678.
19. Preston, M. J., S. M. J. Fleiszig, T. S. Zaidi, J. B. Goldberg, V. D. Shortridge, M. L. Vasil, and G. B. Pier. 1995. Rapid and sensitive method for evaluating Pseudomonas aeruginosa virulence factors during corneal infections in mice. Infect. Immun. 63:3497-3501.
20. Preston, M. J., A. A. Gerceker, N. L. Koles, M. Pollack, and G. B. Pier. 1997. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection. Investig. Ophthalmol. Vis. Sci. 38:1418-1425.
21. Stover, C. K., X. Q. Pham, A. L. Erwin, S. D. Mizoguchi, P. Warrener, M. J. Hickey, F. S. Brinkman, W. O. Hufnagle, D. J. Kowalik, M. Lagrou, R. L. Garber, L. Goltry, E. Tolentino, S. Westbrock-Wadman, Y. Yuan, L. L. Brody, S. N. Coulter, K. R. Folger, A. Kas, K. Larbig, R. Lim, K. Smith, D. Spencer, G. K. Wong, Z. Wu, I. T. Paulsen, J. Reizer, M. H. Saier, R. E. Hancock, S. Lory, and M. V. Olson. 2000. Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406:959-964.
22. Theilacker, C., F. Coleman, S. Mueschenborn, M. Grout, and G. B. Pier. 2003. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide/ alginate conjugate vaccine. Infect. Immun. 71:3875-3884.
23. Thomas, P. A., and P. Geraldine. 2007. Infectious keratitis. Curr. Opin. Infect. Dis. 20:129-141.
24. Verhelst, D., C. Koppen, J. Van Looveren, A. Meheus, and M. J. Tassignon. 2006. Contact lens-related corneal ulcers requiring hospitalization: a 7-year retrospective study in Belgium. Acta Ophthalmol. Scand. 84:522-526.
25. Whitchurch, C. B., T. E. Erova, J. A. Emery, J. L. Sargent, J. M. Harris, A. B. T. Semmler, M. D. Young, J. S. Mattick, and D. J. Wozniak. 2002. Phosphorylation of the Pseudomonas aeruginosa response regulator AlgR is essential for type IV fimbria-mediated twitching motility. J. Bacteriol. 184:4544-4554.
26. Willcox, M. D. 2007. Pseudomonas aeruginosa infection and inflammation during contact lens wear: a review. Optom. Vis. Sci. 84:273-278.
27. Wozniak, D. J., T. J. Wyckoff, M. Starkey, R. Keyser, P. Azadi, G. A. O'Toole, and M. R. Parsek. 2003. Alginate is not a significant component of the extracellular polysaccharide matrix of PA14 and PAO1 Pseudomonas aeruginosa biofilms. Proc. Natl. Acad. Sci. USA 100:7907-7912.
28. Young, A. L., A. T. Leung, E. Y. Cheung, L. L. Cheng, A. K. Wong, and D. S. Lam. 2003. Orthokeratology lens-related Pseudomonas aeruginosa infectious keratitis. Cornea 22:265-266.
29. Zaidi, T. S., G. P. Priebe, and G. B. Pier. 2006. A Live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection. Infect. Immun. 74:975-983.